Belka C - Search Results

1

Reduction of cardiac and coronary artery doses in irradiation of left-sided breast cancer during inspiration breath hold : A planning study.

Schönecker S, Heinz C, Söhn M, Haimerl W, Corradini S, Pazos M, Belka C, Scheithauer H. Schönecker S, et al. Among authors: belka c. Strahlenther Onkol. 2016 Nov;192(11):750-758. doi: 10.1007/s00066-016-1039-z. Epub 2016 Sep 8. Strahlenther Onkol. 2016. PMID: 27632341 English.

2

Clinical impact of predictive assays for acute and late radiation morbidity.

Budach W, Classen J, Belka C, Bamberg M. Budach W, et al. Among authors: belka c. Strahlenther Onkol. 1998 Nov;174 Suppl 3:20-4. Strahlenther Onkol. 1998. PMID: 9830451 Review.

3

Mitomycin C in combination with radiotherapy as a potent inhibitor of tumour cell repopulation in a human squamous cell carcinoma.

Budach W, Paulsen F, Welz S, Classen J, Scheithauer H, Marini P, Belka C, Bamberg M. Budach W, et al. Among authors: belka c. Br J Cancer. 2002 Feb 1;86(3):470-6. doi: 10.1038/sj.bjc.6600081. Br J Cancer. 2002. PMID: 11875717 Free PMC article.

4

First experiences of radiation treatment planning with PET/CT.

Paulsen F, Scheiderbauer J, Eschmann SM, Brechtel K, Klein M, Pfannenberg C, Mondry A, Hehr T, Belka C, Bamberg M. Paulsen F, et al. Among authors: belka c. Strahlenther Onkol. 2006 Jul;182(7):369-75. doi: 10.1007/s00066-006-1451-x. Strahlenther Onkol. 2006. PMID: 16826354

5

Risk of second malignancies after prostate irradiation?

Müller AC, Ganswindt U, Bamberg M, Belka C. Müller AC, et al. Among authors: belka c. Strahlenther Onkol. 2007 Nov;183(11):605-9. doi: 10.1007/s00066-007-1786-y. Strahlenther Onkol. 2007. PMID: 17960335 Review.

6

[A special radiation shielding for the radiotherapy of a pregnant patient].

Buchgeister M, Mondry A, Spillner P, Paulsen F, Belka C, Bamberg M. Buchgeister M, et al. Among authors: belka c. Strahlenther Onkol. 2008 Feb;184(2):80-5. doi: 10.1007/s00066-008-1729-2. Strahlenther Onkol. 2008. PMID: 18259699 German.

7

Efficacy of a triple treatment with irradiation, agonistic TRAIL receptor antibodies and EGFR blockade.

Niyazi M, Marini P, Daniel PT, Humphreys R, Jendrossek V, Belka C. Niyazi M, et al. Among authors: belka c. Strahlenther Onkol. 2009 Jan;185(1):8-18. doi: 10.1007/s00066-009-1856-4. Epub 2009 Feb 18. Strahlenther Onkol. 2009. PMID: 19224142

8

Hypofractionated reirradiation for recurrent malignant glioma.

Henke G, Paulsen F, Steinbach JP, Ganswindt U, Isijanov H, Kortmann RD, Bamberg M, Belka C. Henke G, et al. Among authors: belka c. Strahlenther Onkol. 2009 Feb;185(2):113-9. doi: 10.1007/s00066-009-1969-9. Epub 2009 Feb 25. Strahlenther Onkol. 2009. PMID: 19240998

9

Reirradiation with alternating docetaxel-based chemotherapy for recurrent head and neck squamous cell carcinoma: update of a single-center prospective phase II protocol.

Berger B, Belka C, Weinmann M, Bamberg M, Budach W, Hehr T. Berger B, et al. Among authors: belka c. Strahlenther Onkol. 2010 May;186(5):255-61. doi: 10.1007/s00066-010-2082-9. Epub 2010 Apr 26. Strahlenther Onkol. 2010. PMID: 20437016

10

Long-term outcome of mitomycin C- and 5-FU-based primary radiochemotherapy for esophageal cancer.

Wolf M, Zehentmayr F, Niyazi M, Ganswindt U, Haimerl W, Schmidt M, Hölzel D, Belka C. Wolf M, et al. Among authors: belka c. Strahlenther Onkol. 2010 Jul;186(7):374-81. doi: 10.1007/s00066-010-2137-y. Epub 2010 Jun 24. Strahlenther Onkol. 2010. PMID: 20582393

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

666 results

Search Page

Filters